Vasopressin/serotonin interactions in the anterior hypothalamus control aggressive behavior in golden hamsters by Ferris, Craig F. et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Open Access Articles Open Access Publications by UMMS Authors 
1997-06-01 
Vasopressin/serotonin interactions in the anterior hypothalamus 
control aggressive behavior in golden hamsters 
Craig F. Ferris 
University of Massachusetts Medical School 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/oapubs 
 Part of the Life Sciences Commons, and the Medicine and Health Sciences Commons 
Repository Citation 
Ferris CF, Melloni RH, Koppel GA, Perry KW, Fuller RW, Yvon D. (1997). Vasopressin/serotonin interactions 
in the anterior hypothalamus control aggressive behavior in golden hamsters. Open Access Articles. 
Retrieved from https://escholarship.umassmed.edu/oapubs/1181 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Open Access Articles 
by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
Vasopressin/Serotonin Interactions in the Anterior Hypothalamus
Control Aggressive Behavior in Golden Hamsters
Craig F. Ferris,1 Richard H. Melloni Jr,1 Gary Koppel,2 Kenneth W. Perry,2 Ray W. Fuller,2 and Yvon Delville1
1Neuropsychiatric Sciences Program, Department of Psychiatry, University of Massachusetts Medical Center, Worcester,
Massachusetts 01655, and 2Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center,
Indianapolis, IN 46285
Studies in several species of rodents show that arginine vaso-
pressin (AVP) acting through a V1A receptor facilitates offensive
aggression, i.e., the initiation of attacks and bites, whereas
serotonin (5-HT) acting through a 5-HT1B receptor inhibits ag-
gressive responding. One area of the CNS that seems critical
for the organization of aggressive behavior is the basolateral
hypothalamus, particularly the anterior hypothalamic region.
The present studies examine the neuroanatomical and neuro-
chemical interaction between AVP and 5-HT at the level of the
anterior hypothalamus (AH) in the control of offensive aggres-
sion in Syrian golden hamsters. First, specific V1A and 5-HT1B
binding sites in the AH are shown by in vitro receptor autora-
diography. The binding for each neurotransmitter colocalizes
with a dense field of immunoreactive AVP and 5-HT fibers and
putative terminals. Putative 5-HT synapses on AVP neurons in
the area of the AH are identified by double-staining immuno-
cytochemistry and laser scanning confocal microscopy. These
morphological data predispose a functional interaction be-
tween AVP and 5-HT at the level of the AH. When tested for
offensive aggression in a resident/intruder paradigm, resident
hamsters treated with fluoxetine, a selective 5-HT reuptake
inhibitor, have significantly longer latencies to bite and bite
fewer times than vehicle-treated controls. Conversely, AVP
microinjections into the AH significantly shorten the latency to
bite and increase biting attacks. The action of microinjected
AVP to increase offensive aggression is blocked by the pre-
treatment of hamsters with fluoxetine. These data suggest that
5-HT inhibits fighting, in part, by antagonizing the aggression-
promoting action of the AVP system.
Key words: fluoxetine; vasopressin; serotonin; anterior hypo-
thalamus; offensive aggression; V1A receptor; 5-HT1B receptor;
serenic; flank marking
Two neurotransmitter systems implicated in the control of aggres-
sive behavior are arginine vasopressin (AVP) and serotonin (5-
HT). AVP is a neurochemical signal affecting numerous brain
functions (DeWied, 1971; Cooper et al., 1979; Pittman et al., 1982;
Fehm-Wolfsdorf et al., 1988; Dantzer and Bluthe, 1992), includ-
ing aggression (Ferris and Potegal, 1988, Koolhaas et al., 1990,
1991; Potegal and Ferris, 1990; Winslow et al., 1993; Delville et
al., 1996a,b). For example, microinjection of AVP V1A-receptor
antagonist into the anterior hypothalamus (AH) of a hamster
causes a dose-dependent inhibition of offensive aggression, i.e.,
initiated attacks and bites toward a conspecific placed into their
home cage (Ferris and Potegal, 1988). Similarly, AVP receptor
blockade in the AH significantly reduces aggression between
hamsters paired together in a neutral arena (Potegal and Ferris,
1990).
Although AVP facilitates offensive aggression, 5-HT is re-
ported to have the opposite effect and diminishes aggressive
behavior (for review, see Olivier and Mos, 1990). For example,
rats show an increase in offensive aggression after treatment
with neurotoxins that deplete 5-HT levels in the hypothalamus
(Vergnes et al., 1988). Conversely, rats treated with eltopr-
azine, a 5-HT1 receptor agonist, show a dose-dependent de-
crease in offensive aggression (Sijbesma et al., 1990). Several
studies have reported elevations in CNS levels of 5-HT after
treatment with the selective 5-HT reuptake inhibitor fluoxetine
(Guan and McBride, 1988; Auerbach et al., 1989; Perry and
Fuller, 1992). Because activation of 5-HT1 receptors decreases
aggressive behavior, it is not surprising that the general eleva-
tion of extracellular levels of 5-HT in the CNS by selective
5-HT reuptake inhibitors also diminishes aggressive behavior
(Ogren et al., 1980; Olivier et al., 1989; Coccaro et al., 1990;
Haug et al., 1990; Ferris and Delville, 1994; Kavoussi et al.,
1994; Sanchez and Hyttel, 1994; Delville et al., 1996a); how-
ever, the neural substrates and mechanism(s) of action of
selective 5-HT reuptake inhibitors on aggressive behavior re-
main unclear. It is possible that elevated brain levels of 5-HT
inhibit the activity of the AVP system, resulting in a decrease in
aggressive behavior.
The present studies were undertaken to examine the notion
that AVP and 5-HT interact in the AH to control offensive
aggression. We propose that AVP facilitates aggression and
5-HT functions to inhibit the activity of the AVP system in the
AH. To test this hypothesis, in vitro receptor binding and
immunohistochemistry were used to examine the neuroana-
tomical relationship between AVP/5-HT neurotransmitter sys-
tems in the hypothalamus. Specifically, AVP V1A and 5-HT 1B
receptors and AVP and 5-HT fibers and terminals were visu-
alized in the AH. In addition, putative 5-HT synapses were
visualized on AVP neurons in the area of the AH by double-
staining immunofluorescence and laser scanning confocal mi-
croscopy. Then, to examine the functional interaction between
these transmitter systems in the AH, resident males were
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stimulated to fight in response to AVP microinjected into the
AH in the presence and absence of fluoxetine.
MATERIALS AND METHODS
Animals
Male golden hamsters (Mesocricetus auratus) (110–120 gm) obtained from
Harlan Sprague Dawley Laboratories (Indianapolis, IN) were housed indi-
vidually, maintained on a reverse light /dark cycle (14 hr light/10 hr dark;
lights on at 7 P.M.), and provided food and water ad libitum. Animals were
acclimated to the reverse light /dark cycle for at least 2 weeks before they
were tested. All behavioral tests were conducted during the dark phase of the
circadian cycle because of the nocturnal activity of golden hamsters (De-
Coursey, 1964; Zucker and Stephan, 1973).
All animals were acquired and cared for in accordance with the
guidelines published in the National Institutes of Health Guide for the Care
and Use of Laboratory Animals (National Institutes of Health Publications
No. 80-23, Revised 1978).
AVP and 5-HT receptor binding autoradiography
AVP binding sites in the AH were labeled as described previously (Ferris
et al., 1993) and modified slightly for these studies. Animals (n 5 3) were
killed by decapitation, and the brains were removed, frozen on dry ice,
and stored at 280°C. Coronal sections (20 mm) were cut at 210°C in a
cryostat, thaw-mounted onto gelatin-coated slides, and air-dried at room
temperature for no more than 90 min. Tissue sections were held in slide
boxes in evacuated freezer bags containing calcium carbonate granules as
desiccant. On the day of the experiment, sections were warmed to room
temperature for ;90 min and preincubated at room temperature in 0.05
M Tris-HCl buffer, pH 7.3, containing 100 mM NaCl and 100 mM
guanosine 59-triphosphate (Type 11-S, catalog no. G8752; Sigma, St.
Louis, MO) to uncouple any endogenous AVP from receptors. Sections
were then washed for two 5 min periods in Tris buffer, and incubated for
1 hr at room temperature in Tris buffer containing 10 mM MgCl2, 0.01%
bovine serum albumin (Fraction V, catalog no. A7906; Sigma), 0.05%
bacitracin, and 40 IU aprotinin and 50 pM [125I]-[D(CH2)5Sar
7]AVP
(125I-SAVP) (Grzonka et al., 1983). Next, sections were washed in ice-
cold Tris buffer containing 10 mM MgCl2 and 0.2% paraformaldehyde,
with a final wash in ice-cold distilled water to remove any residual salts.
Nonspecific binding was obtained by incubations containing 1 mM unla-
beled AVP. Once they were dried at room temperature, the sections were
apposed to Hyperfilm 3H (Amersham, IL), in x-ray cassettes for 2–3
weeks at 280°C. After removal from the x-ray cassettes, the sections were
counterstained with thionin to identify the neuroanatomical location of
the labeled sites.
5-HT binding sites in the AH were labeled with a selective 5-HT1B
ligand, [125I]-iodocyanopindolol ([125I]CYP) (Hoyer et al.,1985), using
the method described above. The incubation, however, was performed in
the presence of 30 mM isoprenaline to suppress binding to the
b-adrenoreceptors. Nonspecific binding was obtained in the presence of
1 mM unlabeled 5-HT during the incubation.
AVP immunohistochemistry
Hamsters (n 5 4) were decapitated, and their brains were quickly taken
out and fixed by immersion in 10% acrolein (Aldrich Chemical Com-
pany, Milwaukee, WI) in 0.1 M potassium phosphate buffer (KPBS), pH
7.2, for a period of 6 hr. Later, the brains were kept overnight in 20%
sucrose/KPBS. The brains were sliced at 40 mm in a freezing mic-
rotome, and the sections were saved in 0.05 M Tris buffered saline
(TBS), pH 7.6. Immunocytochemistry for AVP was performed on the
sections as described previously (Delville et al., 1994). Briefly, the
sections were pretreated with 1% sodium borohydrite (to eliminate
residual aldehydes), followed by a preincubation in 20% normal goat
serum containing 1% hydrogen peroxide and 0.3% Triton X-100 (to
block nonspecific labeling and to eliminate endogenous peroxide, re-
spectively). The sections were then incubated in primary antiserum for
AVP (rabbit anti-AVP, 1/16,000; ICN ImmunoBiologicals, Lisle, IL)
containing 2% normal goat serum and 0.3% Triton X-100 for 1 hr at
37°C. After they were washed in TBS, the sections were incubated in
the secondary antiserum (biotinylated goat anti-rabbit IgG; Vector,
Burlingame, CA) and labeled with diaminobenzidine (DAB; 0.5 mg /
ml) using the Vectastain ABC Elite kit (Vector). Omission of the
primary antibody or preincubation of the primary antibody with AVP
(50 mM) prevented the immunolabeling.
5-HT immunocytochemistry
Hamsters (n 5 4) were anesthetized by intraperitoneal injection of
sodium pentobarbital, and the brains were fixed by transcardial perfu-
sion with 0.9% heparinized saline followed by 4% paraformaldehyde in
0.1 M PBS. The brains were taken out, post-fixed in 4% paraformalde-
hyde for 30 – 60 min, and kept overnight at 4°C in 20% sucrose in 0.1 M
PBS. Brain sections were processed for immunocytochemistry to 5-HT
after the procedure outlined above for AVP. After preincubation, the
sections were incubated in the primary antibody (rabbit anti-5-HT,
1/1000; Eugene Tech International, Ridgefield Park, NJ) at 40°C for at
least 48 hr. Later sections were incubated in the secondary antibody
(biotinylated goat anti-rabbit, Vector) and labeled with nickel-
conjugated DAB after tertiary incubation (Vectastain ABC Elite kit,
Vector). This procedure resulted in a blue/black labeling of fibers and
varicosities in the forebrain. Omission of the primary antibody pre-
vented any labeling.
Double-immunofluorescence labeling
Double labeling for AVP and 5-HT was performed in 4%
paraformaldehyde-fixed tissue, following a method modified from above.
The sections were first labeled for 5-HT using a goat anti-5-HT (1/200;
Incstar, Stillwater, MN). After incubation in the primary antibody, the
sections were incubated in a biotinylated secondary antibody (horse
anti-goat IgG, Vector) and labeled by incubation in Texas Red-
conjugated avidin D (Vector). Then, the sections were successively incu-
bated in the primary antibody for AVP (rabbit anti-AVP, 1/2000, ICN),
another secondary antibody (biotinylated donkey anti-rabbit IgG; Jack-
son ImmunoResearch Laboratories, West Grove, PA), before being
labeled by incubation in FITC-conjugated avidin D (Vector).
Using this double-labeling procedure we noted some cross-reactivity
between the FITC-conjugated avidin and Texas Red-conjugated avidin
in 5-HT neurons in the dorsal raphe nucleus. This would suggest that
FITC may have displaced some of the Texas Red labeling in this area
of the brain. The Texas Red-conjugated avidin never labeled AVP
neurons, however, and there was no cross-reactivity between fluoro-
chromes in the labeling of 5-HT varicosities and AVP neurons in the
AH. In later experiments, double-labeling of AVP and 5-HT was
performed using secondary antibodies conjugated to FITC or Texas
Red (donkey anti-rabbit conjugated to FITC, donkey anti-goat conju-
gated to Texas Red; Jackson ImmunoResearch Laboratories). With
these antibodies there was no cross-reactivity between labels in the
raphe nucleus; nevertheless, the same pattern of labeling persisted in
the AH, characterized by AVP neurons surrounded by a high density of
5-HT fibers and varicosities.
Digitized serial sections of 0.5 mm each of double-labeled immunoflu-
orescent signals were obtained and reconstructed in three-dimension with
a Zeiss inverted laser scanning confocal microscope (LSM 410). The data
were volume-rendered to enhance the visualization of 5-HT boutons and
putative synapses with VoxelView/ULTRA version 2.0 Volume Render-
ing Software run on a Silicon Graphics IRIS Indigo XS24Z/Elan work
station.
Behavioral assays and drug treatments
Flank marking. Vasopressin is a neurotransmitter critical to the activation
of flank marking, a stereotyped motor behavior used by hamsters to
disseminate odors in the environment (Johnston, 1975; Ferris et al.,
1984). Injecting AVP into the AH triggers intense flank marking behavior
(Ferris et al., 1984), whereas blocking the V1A receptor in this site inhibits
flank marking induced by odors and agonistic encounters (Ferris et al.,
1985, 1986a; Albers et al., 1986). The present studies were designed to
test the hypothesis that 5-HT diminishes aggression by inhibiting the
activity of the AVP system at the level of AH. To this end, we used
odor-induced flank marking to screen for a dose of fluoxetine that might
block the central activity of AVP.
Hamsters (n 5 11) were tested for odor-induced flank marking 1 hr
after an intraperitoneal injection of vehicle (25% DMSO in 0.9%
saline) or 0.2, 2.0, and 20 mg /kg fluoxetine given in a volume of 0.2 ml.
Behavioral testing was performed in one of four Plexiglas cages (24 3
32 3 20 cm) soiled by the odors of other hamsters. All studies were
counterbalanced; each animal received injections of vehicle and vary-
ing concentrations of fluoxetine every fourth day over a period of 16 d.
Animals were exposed only once to each of the four soiled cages. A
flank mark was scored each time a hamster rubbed its flank gland
against the wall or corner of the cage over a 10 min test period. It was
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determined that a dose of 20 mg / kg was effective in blocking odor-
induced flank marking. When the effect of fluoxetine on offensive
aggression was tested, it was observed that a dose of 10 mg / kg tested
on two animals reduced their total number of bites and increased their
latency to bite as compared with vehicle treatment. Hence, in the AVP
microinjection studies we used doses of 10 or 20 mg / kg of fluoxetine as
indicated.
Offensive aggression. A resident/intruder paradigm was used to evaluate
the role of 5-HT in the control of offensive aggression in hamsters.
Hamsters (n 5 6) were housed individually in Plexiglas cages (24 3 32 3
20 cm) for a minimum of 4 weeks. The hamsters chosen for this study
were established breeders. In addition, they were experienced fighters,
and they routinely attacked intruders placed in their home cage. On the
day of testing, these resident animals were given an intraperitoneal
injection of fluoxetine (20 mg / kg) or vehicle in a volume of 0.2 ml. One
hour later, a smaller male intruder was placed into the home cage of the
resident. The resident was scored for latency to bite the intruder, total
number of bites, and total contact time with the intruder over a 10 min
test period. All experiments were observed and videotaped under dim red
illumination. Each resident was tested with both fluoxetine and vehicle,
with 1 week between treatments. The study was counterbalanced and no
resident saw the same intruder more than once.
To control for nonspecific effects of fluoxetine on animal behavior,
sexual motivation and activity in an open field were also measured.
Briefly, immediately after testing for offensive aggression, the intruder
was removed and replaced by a female hamster in estrus. Within mo-
ments of entering the cage, the female would lordose in response to the
tactile exploration of the resident male. The male was timed for latency
to mount and thrust the female from the time the female was placed into
the cage. The encounter was stopped before intromission and ejaculation.
After the test for sexual motivation, the resident male was placed into a
vacated cage soiled with the odors of conspecifics and tested for flank
marking as described above. Immediately afterward, the resident hamster
was placed into a large clean Plexiglas cage (48 3 32 3 40 cm) devoid of
any bedding. This “open field” was delineated into equal quadrants by
tape on the underside of the cage. Animals were scored for motor activity
by counting the number quadrants traversed in 1 min. A two-tailed paired
t test was used to compare the latency to bite, contact time, sexual
motivation, and motor activity between treatments. A Wilcoxon matched-
pairs signed ranks test (two-tailed) was used to compare the total number
of bites and flank marks between treatments.
Microinjection studies
This study was designed to examine the effect of fluoxetine on offensive
aggression facilitated by the microinjection of AVP in the AH. Hamsters
(n 5 10) were anesthetized with sodium pentobarbital (50 mg / kg) and
stereotaxically implanted with 26 gauge microinjection guide cannulae
aimed at the AH as described previously (Ferris et al., 1986a). The
stereotaxic coordinates of the AH were 1.0 mm anterior to bregma, 1.8
mm lateral to the midsagittal suture, 7.5 mm ventral from dura, and
angled at 8°. The interaural line was held at zero with the incisor bar. All
hamsters were allowed to recover from surgery for at least 2 d before
testing. The animals selected for this study were experienced breeders
and fighters, as noted earlier. Animals were tested for offensive aggres-
sion after each of three different treatments: (1) vehicle microinjection in
the absence of fluoxetine, (2) AVP microinjection in the presence of
fluoxetine, and (3) AVP microinjection in the absence of fluoxetine. The
treatment schedule was counterbalanced, and animals were tested once
every 5 d over a 15 day period. On the day of testing, animals were
pretreated with intraperitoneal injections of vehicle (25% DMSO in 0.9%
NaCl) or fluoxetine (10 mg / kg) in a volume of 0.2 ml. Approximately
60–90 min later, the hamsters were microinjected in the AH with either
AVP (0.09 mM in 0.9% NaCl) or saline vehicle in a volume of 100 nl. The
injections were given through a 33 gauge needle attached to a 1 ml
Hamilton syringe by PE-20 tubing. All microinjections were performed
on unanesthetized animals and took no longer than 15 sec. After micro-
injection, animals were returned to their home cage. Two minutes later,
a smaller male was introduced, and the resident was scored for latency to
bite, total bites, and total contact time.
At the conclusion of the microinjection study, animals were killed, and
the brains were fixed by immersion in 10% formalin and sectioned on a
vibratome. The position of the tip of the needle for each microinjection
site was determined on 100 mm transverse sections stained with thionin.
Critical to these studies was the microinjection of AVP in a concen-
tration of 0.09 mM. Although blockade of AVP receptor in the AH
inhibits offensive aggression (Ferris and Potegal, 1988), microinjection of
AVP into the AH in concentrations ranging from 0.27 to 27 mM triggers
intense flank marking (Ferris et al., 1988). Resident hamsters treated with
concentrations of AVP in excess of 0.9 mM flank mark frantically and
ignore intruders placed into their home cage (C. Ferris, unpublished
observation). Thus, the dose of AVP tested in this study was below the
threshold dose used to trigger flank marking.
The latency to bite was evaluated with a repeated measures ANOVA
followed by a paired t test (two-tailed) for significance between treat-
ments. Total bites were analyzed with nonparametric statistics (Friedman
Test followed by Wilcoxon).
RESULTS
AVP/5-HT interactions in the AH
The receptor autoradiogram shown in Figure 1 reveals specific
V1A binding sites in the area of the AH that extends laterally into
the lateral hypothalamus and ventrally to the optic chiasm. In
comparison, Figure 1 also shows a more diffuse pattern of specific
5-HT1B binding sites in this area of the hypothalamus. Note the
almost homogenous distribution of 5-HT binding sites extending
from the third ventricle through the lateral hypothalamus.
In addition to overlapping binding sites for AVP and 5-HT in the
area of the AH, there is a dense plexus of immunoreactive fibers
for each neurochemical signal as shown in Figure 2. AVP immu-
noreactive fibers and cell bodies localized to the nucleus circularis
(NC) and medial supraoptic nucleus (mSON) can be seen in and
around the AH. Although there is an absence of 5-HT cell bodies
in and around the AH, this area is densely innervated by 5-HT
fibers and synaptic boutons reflecting the pattern of 5-HT binding.
The AVP cell groups with fibers that project in and around the
AH, i.e., mSON and NC, all have close contact with 5-HT fibers
and putative terminals. Visualization with laser scanning confocal
microscopy of the AVP neurons in the NC by double-
immunofluorescent labeling for AVP and 5-HT reveals a dense
innervation of 5-HT fibers and synaptic boutons (Fig. 3). Putative
5-HT synapses can be seen along neural processes in a volume-
rendered data set (Fig. 3).
Fluoxetine affects offensive aggression
Treatment of six experienced fighters with fluoxetine (20 mg /
kg) significantly diminished their offensive aggression, as shown
in the top row of Figure 4. After treatment with vehicle,
animals had a mean latency to bite intruders of ,20 sec and a
median of nine bites in a 10 min observation period. After
treatment with fluoxetine, these same animals showed a signif-
icant increase (t(5) 5 11.7; p , 0.001) in the latency to bite and
a decrease in the number of bites (Z 5 2.2; p , 0.05). In fact,
five of the six animals did not bite the intruder at all during the
10 min test period. As expected, fluoxetine treatment signifi-
cantly (Z 5 2.02; p , 0.05) reduced odor-induced flank mark-
ing (top row, Fig. 4). Contact time did not differ between
treatments (t(5) 5 1.7; p . 0.1); the experienced fighters spent
;3 min of the 10 min test period smelling and exploring the
intruder, as shown in the bottom row of Figure 4. Similarly,
there was no significant difference between treatments (Z 5
0.12; p . 0.1) for general motor activity when tested in an open
arena (bottom row, Fig. 4). Interestingly, the time it took to
mount a receptive female placed into the home cage of the
experienced fighters was diminished after fluoxetine treatment,
with a trend toward significance (t(5) 5 2.29; p , 0.1).
Fluoxetine inhibits AVP-induced aggressive behavior
Data on offensive aggression stimulated by the microinjection of
AVP into the AH after treatment with fluoxetine or vehicle from
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10 experienced fighters is shown in Figure 5. There was a signif-
icant difference between treatments for both latency to bite
(F(2,29) 5 30.7; p , 0.001) and number of bites (x
(2) 5 18.2; p ,
0.001). When injected with saline vehicle into the AH after
intraperitoneal vehicle treatment (Veh 1 Veh), resident animals
showed a mean latency of just over 2 min to bite the intruder.
When the same animals were microinjected with AVP into the
AH after intraperitoneal vehicle treatment, the mean latency to
bite was reduced by ;40%. In the presence of fluoxetine, how-
ever, AVP-injected animals showed a latency to bite that was
.400% greater than vehicle treatment. The number of biting
attacks was also significantly influenced by each treatment. Ani-
mals with vehicle treatments showed a median of six bites over a
10 min test period. With AVP treatment the median number of
bites increased by twofold ( p , 0.05); however, treatment with
fluoxetine essentially abolished the effect of AVP on the number
of bites. Six of the 10 experienced fighters failed to bite in the 10
min test period, whereas the remaining animals could muster only
one or two bites with AVP microinjection.
DISCUSSION
The data from this study support the notion that 5-HT diminishes
offensive aggression in golden hamsters, in part, by blocking the
activity of the AVP system in the area of the AH (a model of this
interaction is provided in Fig. 6). To accomplish this, we propose
that 5-HT is acting directly on aggression-facilitating neurons in
the AH to inhibit the excitatory action of AVP neurotransmitter.
In addition, we propose that 5-HT is acting indirectly on
aggression-facilitating neurons in the AH by inhibiting the activity
of AVP neurons in the NC and mSON. These populations of
neurons have been identified previously as potential sources of
AVP neurotransmitter in the AH involved in the control of
agonistic behavior (Ferris et al., 1989, 1990, 1992). The arguments
supporting this hypothesized interaction between AVP and 5-HT
are discussed below.
The possibility that AVP and 5-HT innervate the same neurons in
the AH involved in the integration and motor control of offensive
aggression is supported by the neuroanatomical and neuropharma-
cological data showing a strong presence of both neurotransmitter
systems in the AH. Both V1A and 5-HT1B binding sites are present in
the AH and colocalize with a dense plexus of AVP and 5-HT fibers
and putative terminals. Furthermore, the ability of AVP to facilitate
offensive aggression when microinjected into the AH is blocked after
fluoxetine treatment. This would indicate that 5-HT can inhibit the
action of AVP after it is released from AVP neurons; however, the
present studies using peripheral injection of fluoxetine do not limit
the action of 5-HT to the AH. It is very possible that the global
elevation of 5-HT after treatment with a specific 5-HT reuptake
inhibitor affects multiple sites in the neural network regulating ag-
gression. In preliminary studies, we have noted that 5-HT injected
together with AVP into the AH blocks the flank marking triggered by
the exogenous neuropeptide (C. Ferris, unpublished data). This
would indicate that 5-HT can directly antagonize an AVP-dependent
behavior at the level of the AH.
The primary inhibitory effect of 5-HT on aggression is mediated
through the postsynaptic 5-HT1B receptor subtype (Sijbesma et
al., 1991; Olivier et al., 1995). The importance of the 5-HT1B
receptor was corroborated in a recent study reporting that ho-
mozygous mutant mice lacking the 5-HT1B receptor show en-
hanced aggression toward intruders (Saudou et al., 1994). Be-
cause postsynaptic 5-HT1B receptors seem to be fundamental in
the modulation of offensive aggression, it is reasonable to postu-
late that 5-HT activates these receptors, making a neuron co-
innervated by AVP unresponsive to the excitatory effects of the
neuropeptide. AVP is reported to enhance neuronal excitability in
the hippocampus (Muhlethaler et al., 1982), sympathetic ganglia
Figure 1. AVP and 5-HT receptor binding in the AH of golden hamsters. Shown are autoradiograms of specific binding for [125I]-[D(CH2)5Sar
7]AVP
(A), a selective AVP V1A receptor antagonist, and (2)[
125I]iodocyanopindolol (B), a selective 5-HT1B receptor ligand. The binding shown was performed
on contiguous 20 mm coronal sections. The area outlined over the AH in autoradiogram A is the same approximate area shown in the top
photomicrograph depicting AVP immunoreactivity in Figure 2. oc, Optic chiasm; PVN, paraventricular nucleus; SCN, suprachiasmatic nucleus.
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(Peters and Kreulen, 1985), lateral septum (Raggenbass et al.,
1988), nucleus of the solitary tract (Raggenbass et al., 1989),
paraventricular nucleus (Carette and Poulain, 1989), and supra-
chiasmatic nucleus (Liou and Albers, 1989). From a mechanistic
standpoint, AVP acting through a V1-like receptor can generate a
persistent inward sodium current when applied to facial motoneu-
rons (Raggenbass et al., 1991). This depolarizing current is
voltage-gated and tetrodotoxin insensitive and contributes to sus-
tained depolarizing potentials that may facilitate repetitive firing.
The intracellular mechanisms for this AVP-mediated depolarizing
current is unknown but may be regulated, in part, by increases in
cAMP (Green and Gillette, 1983). Raggenbass and coworkers
(1991) propose that AVP may indirectly increase cAMP levels
through V1A-coupled activation of phospholipase C and suppres-
sion of guanine nucleotide-binding protein inhibition of adenylate
cyclase.
5-HT acting through the 5-HT1B receptor can inhibit forskolin-
stimulated adenylate cyclase activity in the substantia nigra (Bou-
helal et al., 1988; Schoeffter and Hoyer, 1989). In various cell
lines, the 5-HT1B receptor is reported to mediate the inhibition of
cAMP accumulation (Murphy and Bylund, 1989; Giles et al.,
1994; Schoeffter et al., 1995). If both V1A and 5-HT1B receptors
appear on the same neurons controlling aggression, it is possible
that 5-HT may offset the excitatory effects of AVP, blocking attack
behavior.
The potential for 5-HT acting directly on the AVP neuron is
also supported by the neuroanatomical data. With double-
immunostaining for AVP and 5-HT we have identified putative
5-HT synapses on AVP neurons in golden hamsters, particu-
larly in the area of the mSON and NC, two populations of AVP
neurons that have been identified as innervating the AH and
are involved in the regulation of agonistic behavior (Ferris et
al., 1989, 1990, 1992). The source of 5-HT innervation to the
AVP system in the hypothalamus is the nucleus of the raphe
(Sawchenko et al., 1983). The presence of putative 5-HT syn-
apses on AVP neurons raises the possibility that fluoxetine can
inhibit aggression by diminishing or blocking the electrical
activity of AVP neurons and the release of AVP from nerve
terminals. More than 30% of the neurosecretory neurons in the
PVN identified by antidromic stimulation of the neurohypoph-
ysis are inhibited by microiontophoresis of 5-HT (Moss et al.,
1972). This effect is even more robust in the SON, because all
cells identified by antidromic stimulation show diminished elec-
trical activity with 5-HT application (Barker et al., 1971).
Indeed, peripheral injection of fluoxetine results in an eleva-
tion in extracellular 5-HT levels concomitant with a signifi-
Figure 2. Light-field photomicrographs of coronal sections
through the golden hamster hypothalamus. Shown are argi-
nine vasopressin (AVP) and serotonin (5-HT ) immunoreac-
tivity associated with the anterior hypothalamus (AH ). The
star shown in the AVP photomicrograph depicts the same
approximate area shown in the bottom photomicrograph of
5-HT immunoreactivity. Scale bars: top, 200 mm; bottom, 75
mm. NC, Nucleus circularis; mSON, medial supraoptic nu-
cleus; oc, optic chiasm.
Ferris et al. • Neurobiological Regulation of Aggression in Golden Hamsters J. Neurosci., June 1, 1997, 17(11):4331–4340 4335
cance decrease in AVP levels measured in the AH by micro-
dialysis (Ferris, 1996).
The notion that 5-HT might function to inhibit the release of
AVP was supported by a recent clinical study of personality-
disordered subjects with a history of “fighting and assault”
(Coccaro, 1996). These subjects showed a significant positive
correlation between CSF levels of AVP and aggression. In
addition, these subjects were judged to have a hyporeactive
5-HT system as assessed by fenfluramine challenge. Fenflura-
mine is a 5-HT-releasing drug that normally stimulates prolac-
tin release as a neuroendocrine measure of central 5-HT ac-
tivity. Subjects with a history of inappropriate aggressive
behavior show a blunted prolactin release in response to fen-
fluramine (Coccaro et al., 1989; O’Keane et al., 1992). This
would also seem to be true in nonhuman primates: macaque
monkeys show increased aggressive gestures that negatively
correlate with diminished prolactin release in response to fen-
fluramine (Kyes et al., 1995). Thus, in humans, a hyporeactive
5-HT system may result in enhanced CNS levels of AVP and
the facilitation of impulsive, aggressive behavior.
5-HT has long been considered an important neurotransmitter
in the regulation of impulsive and aggressive behavior in humans
and nonhuman primates. Subjects with a life history of aggres-
sion present with low levels of the 5-HT metabolite
5-hydroxyindolacetic acid (5-HIAA) in their CSF (Brown et al.,
1979, 1982). Low levels of 5-HT metabolite are indicative of
diminished 5-HT release. Low levels of CSF 5-HIAA also corre-
late with adult impulsive violent behavior (Linnoila et al., 1983),
alcohol-associated violence (Virkkunen et al., 1995), and impul-
sive disruptive behavior in children (Kruesi et al., 1990). In free-
ranging rhesus monkeys, low levels of CSF 5-HIAA correlate with
increased aggression and risk taking (Higley et al., 1992; Mehlman
et al., 1994). The levels of CSF 5-HIAA in talapoin monkeys with
an established social hierarchy are the lowest in high ranking
animals and highest in subordinates (Yodyingyuad et al., 1985).
The high levels of CSF 5-HIAA in subordinates is a persistent
Figure 3. Photomicrographs of arginine vasopressin (AVP) and serotonin (5-HT ) revealed by double-labeling immunocytochemistry. Shown are AVP
and 5-HT fluorescent immunoreactivity acquired through laser scanning confocal microscopy. The same single optical plane is shown for both
neurochemical signals in the top black and white photographs. The combination of both digitized images is shown in color on the top right panel. The AVP
is depicted in bright yellow and the 5-HT appears as a red/orange. A volume-rendered data set of serial optical sections through the AVP neuron denoted
with the star is shown in the bottom color photograph. The green stippling is 5-HT varicosities and putative synapses clustered around the red-colored AVP
neuron (denoted by the star). Scale bars: top, 50 mm; bottom, 30 mm.
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condition accrued to their low social status characterized by high
levels of withdrawal and diminished aggressive and reproductive
behavior.
Corroborating the human and monkey studies are neurobiolog-
ical data from rodents linking 5-HT to the inhibition of aggression
responding (Ellison, 1976; McMillen et al., 1987; Vergnes et al.,
1988). As mentioned earlier, in a resident /intruder model, elto-
prazine, the 5-HT1 agonist, produces a dose-dependent decrease
in offensive aggression in a rat resident /intruder model without
altering other behaviors, including defensive aggression (Sijbesma
et al., 1990). This unique pharmacological profile fits a class of
drugs called “serenics” (Olivier and Mos, 1990). A serenic would
hypothetically reduce or delay the onset of attack behavior with-
out interfering with cognitive, social, appetitive, or sexual behav-
iors, while retaining the ability to fight back. In the present studies
on hamsters, we observed a serenic-like profile for fluoxetine: it
significantly decreases offensive aggression in experienced fighters
and leaves other behaviors like social interest, sexual activity, and
motor activity intact.
Multiple studies have shown AVP to be an important neuro-
transmitter affecting agonistic behavior associated with the estab-
lishment and maintenance of dominant /subordinate relationships
between hamsters (for review, see Ferris, 1992). Our results
clearly show that hamsters injected with AVP in the AH display a
significant increase in offensive aggression toward intruders. Past
studies in hamsters, using AVP receptor antagonists microin-
jected into the AH, produced a dose-dependent inhibition of
offensive aggression of a resident male toward an intruder (Ferris
and Potegal, 1988) and a decrease in aggression between pairs of
conspecifics in a neutral arena (Potegal and Ferris, 1990). The
ability of AVP to modulate offensive aggression is not limited to
the AH, however. Microinjection of AVP into the ventrolateral
hypothalamus of the hamster facilitates offensive aggression
(Delville et al., 1996b), and infusion of AVP into the amygdala or
lateral septum facilitates offensive aggression in castrated rats
(Koolhaas et al., 1990, 1991).
Interestingly, the behavioral effects of blocking AVP receptors
in the AH of hamsters are similar to those of fluoxetine. Not only
Figure 4. Shown are the means and medians of several behavioral measures recorded from six experienced fighters with and without fluoxetine treatment.
The latency to bite, the number of bites, and contact time were recorded against an intruder over a 5 min test period. Odor-induced flank marks were
recorded in a vacated soiled cage of another male conspecific over a 5 min period. Latency to mount was recorded against a receptive female placed into
the cage, and motor activity was recorded in a large open arena divided into quadrants.
Figure 5. Shown are the means and medians of two measures of offensive
aggression. The latency to bite and number of bites were recorded in 10
experienced fighters treated with each of the three injection regimens
noted (intraperitoneal injection 1 anterior hypothalamic microinjection).
The behavioral measures were recorded against an intruder over a 10 min
test period.
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does AVP receptor antagonist increase the latency to bite and
decrease the total number of bites toward intruders, it also acts
like a serenic: other social behaviors, general activity, and sexual
behavior are unaffected. Given that AVP can affect numerous
brain functions at multiple sites in the CNS, however, it is unlikely
that an AVP receptor antagonist blocking all V1a receptors would
selectively inhibit offensive aggression independent of other AVP-
mediated behaviors.
The search for biological mechanisms and anatomical sub-
strates underlying the interactions between functionally op-
posed neurotransmitter systems is an important aspect of the
neurobiology of aggression. The ability of AVP to affect offen-
sive aggression at multiple sites in the CNS of different species
is evidence that this neurochemical system may have a broad
physiological role in enhancing arousal during stressful agonis-
tic encounters, lowering the threshold for offensive aggression,
and facilitating attack behavior. Likewise, 5-HT is broadly
distributed throughout the CNS and seems essential for control
of impulsivity and aggression in a range of species. 5-HT may
have a direct inhibitory effect on the neural network controlling
aggression or may act indirectly by depressing the activity of a
neurotransmitter system that activates aggression. The present
study provides evidence that the anti-aggressive activity of
5-HT may be attributable in part to an inhibitory effect on the
AVP system in the AH.
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